NEEMA NAVAI

TitleAssistant Professor
InstitutionMD Anderson
DepartmentUrology
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Contieri R, Tan WS, Grajales V, Hensley PJ, Martini A, Bree K, Myers A, Nogueras-Gonzalez G, Navai N, Dinney CP, Guo C, Kamat AM. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy. BJU Int. 2024 Feb 19. PMID: 38374533.
      Citations:    Fields:    
    2. Sood A, Rudzinski JK, Labbate CV, Hensley PJ, Bree KK, Guo CC, Alhalabi O, Campbell MT, Siefker-Radtke AO, Navai N, Dinney CPN, Gao J, Kamat AM. Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience. J Urol. 2024 Feb; 211(2):241-255. PMID: 37922370.
      Citations:    Fields:    Translation:Humans
    3. Alhalabi O, Wilson N, Xiao L, Lin Y, Khandelwal J, Moussa MJ, Msaouel P, Navai N, Gao J, Kamat AM, Pilie P, Shah AY, Goswami S, Matin S, Kovitz C, Holla V, Guo C, Czerniak B, Logothetis C, Corn PG, Dinney CPN, Campbell MT, Hansel DE, Tannir NM, Siefker-Radtke AO. Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract. Eur Urol Oncol. 2023 12; 6(6):611-620. PMID: 37833193.
      Citations:    Fields:    Translation:Humans
    4. Bree K, Navai N. Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply. J Urol. 2023 12; 210(6):839-840. PMID: 37747095.
      Citations:    Fields:    Translation:Humans
    5. Bree KK, Navai N. Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply. J Urol. 2023 12; 210(6):839. PMID: 37747096.
      Citations:    Fields:    Translation:Humans
    6. Contieri R, Hensley PJ, Tan WS, Grajales V, Bree K, Nogueras-Gonzalez GM, Lee BH, Navai N, Dinney CP, Kamat AM. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Gu?rin or Early Radical Cystectomy. Eur Urol Oncol. 2023 12; 6(6):590-596. PMID: 37558542.
      Citations:    Fields:    
    7. Contieri R, Grajales V, Tan WS, Martini A, Sood A, Hensley P, Bree K, Navai N, Dinney CP, Kamat AM, Lobo N, Nogueras-Gonzalez GM, Guo CC. Impact of age >70?years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu?rin. BJU Int. 2024 01; 133(1):63-70. PMID: 37442564; PMCID: PMC10787034.
      Citations:    Fields:    
    8. Tan WS, McElree IM, Davaro F, Steinberg RL, Bree K, Navai N, Dinney CP, O'Donnell MA, Li R, Kamat AM, Packiam VT. Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Gu?rin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. 2023 10; 6(5):531-534. PMID: 37468392.
      Citations:    Fields:    
    9. Tan WS, Grajales V, Bree K, Li R, Nogueras-Gonzalez GM, Navai N, Dinney C, Kamat AM. Bacillus Calmette-Gu?rin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal? BJU Int. 2023 10; 132(4):384-386. PMID: 37246493.
      Citations:    Fields:    Translation:HumansCells
    10. Wang XS, Bree KK, Navai N, Kamal M, Shen SE, Letona E, Cleeland CS, Shi Q, Gottumukkala V. Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study. Cancers (Basel). 2023 Jun 04; 15(11). PMID: 37297013; PMCID: PMC10252507.
      Citations:    
    11. Bree KK, Kokorovic A, Westerman ME, Hensley PJ, Brooks NA, Qiao W, Shen Y, Kamat AM, Dinney CP, Navai N. Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply. J Urol. 2023 08; 210(2):254-255. PMID: 37211780.
      Citations:    Fields:    Translation:Humans
    12. Tan WS, Grajales V, Contieri R, Hensley P, Bree K, Msaouel P, Guo CC, Nogueras-Gonzalez GM, Navai N, Dinney CP, Kamat AM. Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes. Eur Urol Open Sci. 2023 Jul; 53:16-22. PMID: 37441349; PMCID: PMC10334230.
      Citations: 1     
    13. Hensley PJ, Duan Z, Bree K, Sood A, Zhao H, Lobo N, Contieri R, Campbell MT, Guo CC, Navai N, Williams SB, Dinney CP, Kamat AM. Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship. Urol Oncol. 2023 02; 41(2):108.e11-108.e17. PMID: 36404232.
      Citations:    Fields:    Translation:Humans
    14. Bree KK, Kokorovic A, Westerman ME, Hensley PJ, Brooks NA, Qiao W, Shen Y, Kamat AM, Dinney CP, Navai N. Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic. J Urol. 2023 01; 209(1):140-149. PMID: 36250944.
      Citations: 1     Fields:    Translation:Humans
    15. Kamal M, Navai N, Bree KK, Williams LA, Cleeland CS, Shen SE, Wang XS. Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting. Cancers (Basel). 2022 Aug 12; 14(16). PMID: 36010890; PMCID: PMC9405694.
      Citations:    
    16. Labbate CV, Hensley PJ, Miest TS, Qiao W, Adibi M, Shah AY, Chery L, Papadopoulos J, Siefker-Radtke AO, Gao J, Guo CC, Czerniak BA, Navai N, Kamat AM, Dinney CP, Campbell MT, Matin SF. Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2022 10; 40(10):454.e17-454.e23. PMID: 35961847.
      Citations:    
    17. Bondaruk J, Jaksik R, Wang Z, Cogdell D, Lee S, Chen Y, Dinh KN, Majewski T, Zhang L, Cao S, Tian F, Yao H, Kus P, Chen H, Weinstein JN, Navai N, Dinney C, Gao J, Theodorescu D, Logothetis C, Guo CC, Wang W, McConkey D, Wei P, Kimmel M, Czerniak B. Erratum: The origin of bladder cancer from mucosal field effects. iScience. 2022 Jul 15; 25(7):104715. PMID: 35811851; PMCID: PMC9263966.
      Citations:    
    18. Bree KK, Hensley PJ, Lobo N, Brooks NA, Nogueras-Gonzalez GM, Guo CC, Navai N, Grossman HB, Dinney CP, Kamat AM. Reply by Authors. J Urol. 2022 08; 208(2):290-291. PMID: 35770497.
      Citations:    Fields:    
    19. Bree KK, Hensley PJ, Lobo N, Brooks NA, Nogueras-Gonzalez GM, Guo CC, Navai N, Grossman HB, Dinney CP, Kamat AM. All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Gu?rin Response in High-Grade Ta Tumors. J Urol. 2022 08; 208(2):284-291. PMID: 35770498.
      Citations:    Fields:    Translation:HumansCells
    20. Bondaruk J, Jaksik R, Wang Z, Cogdell D, Lee S, Chen Y, Dinh KN, Majewski T, Zhang L, Cao S, Tian F, Yao H, Kus P, Chen H, Weinstein JN, Navai N, Dinney C, Gao J, Theodorescu D, Logothetis C, Guo CC, Wang W, McConkey D, Wei P, Kimmel M, Czerniak B. The origin of bladder cancer from mucosal field effects. iScience. 2022 Jul 15; 25(7):104551. PMID: 35747385; PMCID: PMC9209726.
      Citations:    
    21. Cohen AB, Stump L, Krumholz HM, Cartiera M, Jain S, Scott Sussman L, Hsiao A, Lindop W, Ying AK, Kaul RL, Balcezak TJ, Tereffe W, Comerford M, Jacoby D, Navai N. Aligning mission to digital health strategy in academic medical centers. NPJ Digit Med. 2022 Jun 02; 5(1):67. PMID: 35654885; PMCID: PMC9163186.
      Citations:    
    22. Adibi M, McCormick B, Economides MP, Petros F, Xiao L, Guo C, Shah A, Kamat AM, Dinney C, Navai N, Gao J, Siefker-Radtke A, Matin SF, Campbell MT. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2022 04; 20(2):176-182. PMID: 35039231.
      Citations:    Fields:    Translation:Humans
    23. Lobo N, Hensley PJ, Bree KK, Nogueras-Gonzalez GM, Navai N, Dinney CP, Sylvester RJ, Kamat AM. Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Gu?rin. Eur Urol Oncol. 2022 02; 5(1):84-91. PMID: 34920986.
      Citations:    Fields:    Translation:Humans
    24. Lobo N, Bree KK, Hensley PJ, Nogueras-Gonzalez GM, Abraham P, Navai N, Dinney CP, Kamat AM. Reduced-dose bacillus Calmette-Gu?rin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre. BJU Int. 2022 09; 130(3):323-330. PMID: 34847263.
      Citations:    Fields:    
    25. Lobo N, Hensley PJ, Bree KK, Nogueras-Gonzalez GM, Navai N, Dinney CP, Kamat AM. Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Gu?rin? BJU Int. 2022 10; 130(4):463-469. PMID: 34854189.
      Citations:    Fields:    
    26. Khanna A, Miest T, Sharma V, Campbell R, Hensley P, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Murthy PB, Haber GP, Navai N, Kamat AM, Dinney C, Lee B, Boorjian SA. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience. J Urol. 2022 Mar; 207(3):551-558. PMID: 34694143.
      Citations:    Fields:    Translation:Humans
    27. Bree KK, Navai N. Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Reply. J Urol. 2022 02; 207(2):476-477. PMID: 34694162.
      Citations:    Fields:    Translation:Humans
    28. Alhalabi O, Campbell MT, Xiao L, Adriazola AC, Wilson NR, Siefker-Radtke AO, Corn PG, Zurita A, Jonasch E, Gao J, Adibi M, Kamat AM, Navai N, Pisters LL, Dinney C, Matin SF, Shah AY. Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma. BJUI Compass. 2022 Jan; 3(1):37-44. PMID: 35475152; PMCID: PMC8988842.
      Citations: 2     
    29. Hensley PJ, Bree KK, Campbell MT, Alhalabi O, Kokorovic A, Miest T, Nogueras-Gonzalez GM, Gao J, Siefker-Radtke AO, Guo CC, Navai N, Dinney CP, Kamat AM. Reply by Authors. J Urol. 2021 11; 206(5):1267. PMID: 34372685.
      Citations:    Fields:    
    30. Sood A, Keeley J, Palma-Zamora I, Novara G, Elshaikh M, Jeong W, Hensley P, Navai N, Peabody JO, Trinh QD, Rogers CG, Menon M, Abdollah F. High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival. Urol Oncol. 2022 02; 40(2):62.e1-62.e11. PMID: 34348860.
      Citations:    Fields:    Translation:Humans
    31. Hensley PJ, Bree KK, Campbell MT, Alhalabi O, Kokorovic A, Miest T, Nogueras-Gonzalez GM, Gao J, Siefker-Radtke AO, Guo CC, Navai N, Dinney CP, Kamat AM. Progression of Disease after Bacillus Calmette-Gu?rin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy. J Urol. 2021 11; 206(5):1258-1267. PMID: 34184926.
      Citations: 1     Fields:    Translation:Humans
    32. Westerman ME, Bree KK, Kokorovic A, Frank J, Wang XS, Kamat AM, Dinney CPN, Navai N. What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs. Urology. 2021 11; 157:181-187. PMID: 34186127.
      Citations: 1     Fields:    Translation:Humans
    33. Bree KK, Hensley PJ, Brooks N, Matulay J, Nogueras-Gonzalez GM, Navai N, Dinney CP, Kamat AM. Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center. World J Urol. 2021 Nov; 39(11):4143-4149. PMID: 34117914.
      Citations: 1     Fields:    Translation:Humans
    34. Kokorovic A, Westerman ME, Krause K, Hernandez M, Brooks N, Dinney CPN, Kamat AM, Navai N. Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate. Bladder Cancer. 2021 May 25; 7(2):243-252. PMID: 34195319; PMCID: PMC8204151.
      Citations:    
    35. Hensley PJ, Bree KK, Brooks N, Matulay J, Li R, Navai N, Grossman HB, Dinney CP, Kamat AM, Nogueras Gonz?lez GM. Time interval from transurethral resection of bladder tumour to bacille Calmette-Gu?rin induction does not impact therapeutic response. BJU Int. 2021 11; 128(5):634-641. PMID: 33783950.
      Citations: 1     Fields:    Translation:Humans
    36. Hensley PJ, Bree KK, Brooks N, Matulay J, Li R, Nogueras-Gonzalez GM, Nagaraju S, Navai N, Grossman HB, Dinney CP, Kamat AM. Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Gu?rin Therapy Outcomes. Eur Urol Oncol. 2022 06; 5(3):347-356. PMID: 33935020; PMCID: PMC8553807.
      Citations:    Fields:    Translation:Humans
    37. Bree KK, Hensley PJ, Westerman ME, Kokorovic A, Nogueras-Gonzalez GM, Dinney CP, Kamat AM, Navai N. Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. J Urol. 2021 Sep; 206(3):577-585. PMID: 33872050.
      Citations: 1     Fields:    Translation:Humans
    38. Kukreja JB, Li R, Narayan VM, Lim A, Seif M, Wang X, Kamat A, Dinney C, Navai N. Oncologic Equipoise Between Robotic and Open Radical Cystectomy. J Endourol. 2021 08; 35(8):1168-1176. PMID: 33619985.
      Citations:    Fields:    Translation:Humans
    39. Matulay JT, Li R, Hensley PJ, Brooks NA, Narayan VM, Grossman HB, Navai N, Dinney CPN, Kamat AM. Reply by Authors. J Urol. 2021 06; 205(6):1620-1621. PMID: 33734859.
      Citations:    Fields:    
    40. Zacharias NM, Wang L, Maity T, Li L, Millward SW, Karam JA, Wood CG, Navai N. Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo. Int J Mol Sci. 2021 Mar 11; 22(6). PMID: 33799686; PMCID: PMC8001211.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    41. Bree KK, Hensley PJ, Brooks NA, Matulay J, Li R, Nogueras Gonzalez GM, Navai N, Grossman HB, Matin SF, Dinney CPN, Kamat AM. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer. BJU Int. 2021 11; 128(5):568-574. PMID: 33484074.
      Citations:    Fields:    Translation:Humans
    42. Matulay JT, Li R, Hensley PJ, Brooks NA, Narayan VM, Grossman HB, Navai N, Dinney CPN, Kamat AM. Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Gu?rin: Implications for Clinical Trial Design. J Urol. 2021 06; 205(6):1612-1621. PMID: 33502236.
      Citations: 2     Fields:    Translation:Humans
    43. Kukreja JB, Seif MA, Mery MW, Incalcaterra JR, Kamat AM, Dinney CP, Shah JB, Feeley TW, Navai N. Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers. Urol Oncol. 2021 04; 39(4):237.e1-237.e5. PMID: 33308972.
      Citations:    Fields:    Translation:Humans
    44. Brooks NA, Kokorovic A, Xiao L, Matulay JT, Li R, Ranasinghe WKB, Nagaraju S, Shen Y, Gao J, Navai N, Dinney CPN, Grossman HB, Kamat AM. The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu?rin. BJU Int. 2021 07; 128(1):65-71. PMID: 33210440.
      Citations: 1     Fields:    Translation:Humans
    45. Gao J, Navai N, Alhalabi O, Siefker-Radtke A, Campbell MT, Tidwell RS, Guo CC, Kamat AM, Matin SF, Araujo JC, Shah AY, Msaouel P, Corn P, Wang J, Papadopoulos JN, Yadav SS, Blando JM, Duan F, Basu S, Liu W, Shen Y, Zhang Y, Macaluso MD, Wang Y, Chen J, Zhang J, Futreal A, Dinney C, Allison JP, Goswami S, Sharma P. Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat Med. 2020 12; 26(12):1845-1851. PMID: 33046869.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    46. Westerman ME, Kokorovic A, Wang XS, Lim A, Garcia-Gonzalez A, Seif M, Wang R, Kamat AM, Dinney CPN, Navai N. Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis. J Sex Med. 2020 10; 17(10):1995-2004. PMID: 32713807.
      Citations:    Fields:    Translation:Humans
    47. Mokkapati S, Porten SP, Narayan VM, Lim AH, Jayaratna IS, Roth B, Cheng T, Navai N, Wszolek M, Melquist J, Manyam G, Choi W, Broom B, Pretzsch S, Czerniak B, McConkey DJ, Dinney CPN. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Mol Cancer Res. 2020 06; 18(6):811-821. PMID: 32122956.
      Citations:    Fields:    Translation:HumansAnimalsCells
    48. Narayan VM, Seif MA, Lim AH, Li R, Matulay JT, Kukreja JB, Qiao W, Hwang H, Shah JB, Pisters L, Kamat AM, Dinney C, Navai N. Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes. Urol Oncol. 2020 04; 38(4):247-254. PMID: 31953001.
      Citations: 1     Fields:    Translation:Humans
    49. Pessoa R, Navai N, Kukreja JB. EDITORIAL COMMENT. Urology. 2020 01; 135:64-65. PMID: 31895682.
      Citations:    Fields:    Translation:Humans
    50. Williams WH, Cata JP, Lasala JD, Navai N, Feng L, Gottumukkala V. Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy. Br J Anaesth. 2020 02; 124(2):164-172. PMID: 31780139.
      Citations: 3     Fields:    Translation:Humans
    51. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, Kuban DA. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer. 2020 02 01; 126(3):506-514. PMID: 31742674; PMCID: PMC6980273.
      Citations: 7     Fields:    Translation:Humans
    52. Lim AH, Narayan VM, Navai N. The Role of Surgery in Initially Metastatic Urothelial Carcinoma: Informing a Definitive Trial. Eur Urol Oncol. 2020 02; 3(1):102-103. PMID: 31501083.
      Citations:    Fields:    Translation:Humans
    53. Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, Kamat AM, Pisters LL, Dinney CP, Navai N, Gonz?lez GMN. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol. 2019 Dec; 37(12):2691-2698. PMID: 30864005.
      Citations: 4     Fields:    Translation:Humans
    54. Marcus RK, Lillemoe HA, Rice DC, Mena G, Bednarski BK, Speer BB, Ramirez PT, Lasala JD, Navai N, Williams WH, Kim BJ, Voss RK, Gottumukkala VN, Aloia TA. Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis. Ann Surg Oncol. 2019 Mar; 26(3):782-790. PMID: 30627879; PMCID: PMC6878764.
      Citations: 5     Fields:    Translation:Humans
    55. Li R, Tabayoyong WB, Guo CC, Navai N, Grossman HB, Dinney CP, Kamat AM, Gonz?lez GMN. Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease. Eur Urol. 2019 01; 75(1):8-10. PMID: 30301695.
      Citations: 6     Fields:    Translation:Humans
    56. Li R, Metcalfe MJ, Tabayoyong WB, Guo CC, Navai N, Grossman HB, Dinney CP, Kamat AM, Nogueras Gonz?lez GM. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign. Eur Urol Oncol. 2019 05; 2(3):286-293. PMID: 31200843.
      Citations: 3     Fields:    Translation:Humans
    57. Kukreja JB, Metcalfe MJ, Qiao W, Kamat AM, Dinney CPN, Navai N. Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort. Eur Urol Focus. 2020 01 15; 6(1):88-94. PMID: 30033071.
      Citations: 7     Fields:    Translation:Humans
    58. Balasubramanian A, Metcalfe MJ, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF. Salvage topical therapy for upper tract urothelial carcinoma. World J Urol. 2018 Dec; 36(12):2027-2034. PMID: 29804202; PMCID: PMC6261784.
      Citations: 1     Fields:    Translation:Humans
    59. Mmeje CO, Benson CR, Jayaratna IS, Gao J, Siefker-Radtke AO, Kamat AM, Dinney CP, Navai N, Shah JB, Nogueras-Gonz?lez GM. Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy. BJU Int. 2018 07; 122(1):89-98. PMID: 29569824.
      Citations: 9     Fields:    Translation:Humans
    60. Kukreja JB, Shi Q, Chang CM, Seif MA, Sterling BM, Chen TY, Creel KM, Kamat AM, Dinney CP, Navai N, Shah JB, Wang XS. Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy. Surg Innov. 2018 Jun; 25(3):242-250. PMID: 29557251; PMCID: PMC5995564.
      Citations: 7     Fields:    Translation:Humans
    61. Li R, Metcalfe M, Kukreja J, Navai N. Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review. Bladder Cancer. 2018 Jan 20; 4(1):31-40. PMID: 29430505; PMCID: PMC5798530.
      Citations: 5     
    62. Chapin BF, Nguyen JN, Achim MF, Navai N, Williams SB, Prokhorova IN, Wang X, Tapia EMLN, Davis JW, Troncoso P. Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer. Prostate Cancer Prostatic Dis. 2018 06; 21(2):221-227. PMID: 29230008.
      Citations: 6     Fields:    Translation:Humans
    63. Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int. 2018 04; 121(4):540-548. PMID: 28941030.
      Citations: 8     Fields:    Translation:Humans
    64. Li R, Metcalfe MJ, Ferguson JE, Mokkapati S, Dinney CP, Navai N, McConkey DJ, Sahai SK, Kamat AM, Nogueras Gonz?lez GM. Effects of thiazolidinedione in patients with active bladder cancer. BJU Int. 2018 02; 121(2):244-251. PMID: 28872778; PMCID: PMC5780258.
      Citations: 3     Fields:    Translation:Humans
    65. Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int. 2018 01; 121(1):69-76. PMID: 28710901; PMCID: PMC6126916.
      Citations: 6     Fields:    Translation:Humans
    66. Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes. J Endourol. 2017 09; 31(9):946-953. PMID: 28731777; PMCID: PMC5915259.
      Citations: 9     Fields:    Translation:Humans
    67. Metcalfe MJ, Ferguson JE, Li R, Xiao L, Guo CC, Czerniak BA, Siefker-Radtke A, Pretzsch SM, Navai N, McConkey DJ, Kamat AM, Campbell M, Dinney C. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Eur Urol Focus. 2017 12; 3(6):577-583. PMID: 28753816; PMCID: PMC5767145.
      Citations: 3     Fields:    Translation:Humans
    68. Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney C. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget. 2017 May 23; 8(21):34205-34222. PMID: 27494900; PMCID: PMC5470961.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    69. Kukreja JB, Porten S, Golla V, Ho PL, Noguera-Gonzalez G, Navai N, Kamat AM, Dinney CPN, Shah JB. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. Eur Urol Focus. 2018 09; 4(5):720-724. PMID: 28753837.
      Citations: 7     Fields:    Translation:Humans
    70. Biebighauser KC, Gao J, Rao P, Landon G, Pagliaro L, Dinney CPN, Karam J, Navai N. Non-seminomatous germ cell tumor with bone metastasis only at diagnosis: A rare clinical presentation. Asian J Urol. 2017 Apr; 4(2):124-127. PMID: 29264217; PMCID: PMC5717982.
      Citations:    
    71. Navai N, Benedict WF, Zhang G, Abraham A, Ainslie N, Shah JB, Grossman HB, Kamat AM, Dinney CP. Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon a2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer. Ann Surg Oncol. 2016 11; 23(12):4110-4114. PMID: 27387678; PMCID: PMC5459317.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    72. Navai N, Dinney CP. Oncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy. J Urol. 2016 06; 195(6):1646-7. PMID: 26994308.
      Citations: 3     Fields:    
    73. Mmeje CO, Guo CC, Shah JB, Navai N, Grossman HB, Dinney CP, Kamat AM. Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Gu?rin Therapy: Implication for Clinical Trial Design. Eur Urol. 2016 11; 70(5):778-785. PMID: 26922408; PMCID: PMC5115993.
      Citations: 3     Fields:    Translation:Humans
    74. Ho PL, Willis DL, Patil J, Xiao L, Williams SB, Melquist JJ, Tart K, Parikh S, Shah JB, Delacroix SE, Navai N, Siefker-Radtke A, Dinney CP, Pisters LL, Kamat AM. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urol Oncol. 2016 Feb; 34(2):59.e1-8. PMID: 26421586.
      Citations: 18     Fields:    Translation:Humans
    75. Jayaratna IS, Navai N, Dinney CP. Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer. Transl Androl Urol. 2015 Jun; 4(3):273-82. PMID: 26816830; PMCID: PMC4708231.
      Citations: 4     
    76. Navai N, Matin SF. Words of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy. Eur Urol. 2015 Jan; 67(1):173-174. PMID: 25528394.
      Citations: 1     Fields:    Translation:Humans
    77. Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, Hautmann R, Hogendoorn PC, Netto G, Theodorescu D, James CD, Czerniak B, Miettinen M, Waldman T, Volkmer B, K?fer R. Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet. 2013 Dec; 45(12):1428-30. PMID: 24121789; PMCID: PMC3875130.
      Citations: 95     Fields:    Translation:HumansAnimalsCells
    78. Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol. 2014 Jan; 191(1):40-7. PMID: 23911605; PMCID: PMC4158919.
      Citations: 60     Fields:    Translation:Humans
    79. Dinney CP, Fisher MB, Navai N, O'Donnell MA, Cutler D, Abraham A, Young S, Hutchins B, Caceres M, Kishnani N, Sode G, Cullen C, Zhang G, Grossman HB, Kamat AM, Gonzales M, Kincaid M, Ainslie N, Maneval DC, Wszolek MF, Benedict WF. Phase I trial of intravesical recombinant adenovirus mediated interferon-a2b formulated in Syn3 for Bacillus Calmette-Gu?rin failures in nonmuscle invasive bladder cancer. J Urol. 2013 Sep; 190(3):850-6. PMID: 23507396; PMCID: PMC3951790.
      Citations: 38     Fields:    Translation:HumansCellsCTClinical Trials
    80. Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJ. The p63 protein isoform ?Np63a inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem. 2013 Feb 01; 288(5):3275-88. PMID: 23239884; PMCID: PMC3561548.
      Citations: 72     Fields:    Translation:HumansCells
    81. Navai N, Wood CG. Environmental and modifiable risk factors in renal cell carcinoma. Urol Oncol. 2012 Mar-Apr; 30(2):220-4. PMID: 22385993.
      Citations: 13     Fields:    Translation:HumansAnimalsPHPublic Health
    82. Rebuck DA, Zhao LC, Helfand BT, Casey JT, Navai N, Perry KT, Nadler RB. Simple modifications in operating room processes to reduce the times and costs associated with robot-assisted laparoscopic radical prostatectomy. J Endourol. 2011 Jun; 25(6):955-60. PMID: 21457071.
      Citations: 5     Fields:    Translation:Humans
    83. Alphs HH, Navai N, McVary KT, K?hler TS. Preoperative clinical and diagnostic characteristics of patients who require delayed IPP after primary Peyronies repair. J Sex Med. 2010 Mar; 7(3):1262-8. PMID: 20059657.
      Citations: 4     Fields:    Translation:Humans
    84. Nadler RB, Casey JT, Zhao LC, Navai N, Smith ZL, Zhumkhawala A, Macejko AM. Is the transition from open to robotic prostatectomy fair to your patients? A single-surgeon comparison with 2-year follow-up. J Robot Surg. 2010 Jan; 3(4):201-7. PMID: 27628630.
      Citations: 3     Fields:    
    85. Meeks JJ, Zhao LC, Navai N, Perry KT, Nadler RB, Smith ND. Risk factors and management of urine leaks after partial nephrectomy. J Urol. 2008 Dec; 180(6):2375-8. PMID: 18930268.
      Citations: 29     Fields:    Translation:Humans
    86. Navai N, Erickson BA, Zhao LC, Okotie OT, Gonzalez CM. Complications following urethral reconstructive surgery: a six year experience. Int Braz J Urol. 2008 Sep-Oct; 34(5):594-600; discussion 601. PMID: 18986563.
      Citations: 6     Fields:    Translation:Humans
    87. Navai N, Ramos P, Zhao LC, Meeks JJ, Nadler RB, Smith ND. Why not partial nephrectomy? Urology. 2008 Aug; 72(2):243-6. PMID: 18584853.
      Citations:    Fields:    Translation:Humans
    88. Casey JT, Erickson BA, Navai N, Zhao LC, Meeks JJ, Gonzalez CM. Urethral reconstruction in patients with neurogenic bladder dysfunction. J Urol. 2008 Jul; 180(1):197-200. PMID: 18499188.
      Citations: 6     Fields:    Translation:Humans
    89. Erickson BA, Navai N, Patil M, Chang A, Gonzalez CM. A prospective, randomized trial evaluating the use of hydrogel coated latex versus all silicone urethral catheters after urethral reconstructive surgery. J Urol. 2008 Jan; 179(1):203-6. PMID: 18001794.
      Citations: 1     Fields:    Translation:Humans
    90. Navai N, Yap RL, Gupta R, Fraser TG, Gonzalez CM. Inflammatory pseudotumor of the testis: a novel presentation of acute retroviral syndrome. Int J Urol. 2005 Apr; 12(4):424-6. PMID: 15948738.
      Citations: 2     Fields:    Translation:HumansCells
    91. Saporita AJ, Zhang Q, Navai N, Dincer Z, Hahn J, Cai X, Wang Z. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J Biol Chem. 2003 Oct 24; 278(43):41998-2005. PMID: 12923188.
      Citations: 75     Fields:    Translation:HumansCells
    92. Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy. European Urology.
    93. Is the transition from open to robotic prostatectomy fair to your patients? A single-surgeon comparison with 2-year follow-up. Journal of Robotic Surgery. 3:201-207.
    94. Preoperative clinical and diagnostic characteristics of patients who require delayed ipp after primary Peyronie's repair. Journal of Urology. 184:1392-1393.
    95. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy. Urologic Oncology: Seminars and Original Investigations. 34:59.e1-59.e8.
    96. Annals of Surgical Oncology. 1-5.
    97. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. European Urology Focus.
    98. In vivo microwave-induced porcine kidney thermoablation. Journal of Endourology. 25:908-909.
    99. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles - Commentary. Journal of Endourology. 25:909-910.
    100. Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer. Translational Andrology and Urology. 4:273-282.
    101. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. European Urology, Supplements. 2.
    102. Oncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy. Journal of Urology. 195:1646-1647.
    NAVAI's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (270)
    Explore
    _
    Co-Authors (57)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _